NSAIDs Linked to Considerably Lower Mortality among Colorectal Cancer Survivors

A new research from Fred Hutchison Cancer Research Center finds that use of nonsteroidal anti-inflammatory drugs, or NSAIDs, connected to about 25% reduction in all-cause mortality among long-term colorectal cancer survivors.colorectal cancer survivals

For the study, the researchers have analyzed data from 2,419 newly diagnosed patients in the Colon Cancer Family Registry, having divided them into four groups and encountering such factors as smoking habits, family history, age etc. After this, the scientists conducted statistical analyses.

The first author of the study Xinwei Hua, an epidemiologist at Fred Hutch, says: “We now have a better idea of how NSAID use may benefit a subset of patients diagnosed with colorectal cancer.”